Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 66 entries
Sorted by: Best Match Show Resources per page
Doubts about the drug industry.

Nursing times

Bosanquet N.
PMID: 1134974
Nurs Times. 1975 Jun 12;71(24):913.

No abstract available.

Cite
Bosanquet N. Doubts about the drug industry. Nurs Times. 1975;71(24):913
Bosanquet, N. (1975). Doubts about the drug industry. Nursing times, 71(24), 913.
Bosanquet, N. "Doubts about the drug industry." Nursing times vol. 71,24 (1975): 913.
Bosanquet N. Doubts about the drug industry. Nurs Times. 1975 Jun 12;71(24):913. PMID: 1134974.
Copy Download .nbib Format: NLM
Standard setting.

Journal of parenteral science and technology : a publication of the Parenteral Drug Association

Kieffer RG.
PMID: 3612413
J Parenter Sci Technol. 1987 May-Jun;41(3):80-2.

No abstract available.

Cite
Kieffer RG. Standard setting. J Parenter Sci Technol. 1987;41(3):80-2
Kieffer, R. G. (1987). Standard setting. Journal of parenteral science and technology : a publication of the Parenteral Drug Association, 41(3), 80-2.
Kieffer, R G. "Standard setting." Journal of parenteral science and technology : a publication of the Parenteral Drug Association vol. 41,3 (1987): 80-2.
Kieffer RG. Standard setting. J Parenter Sci Technol. 1987 May-Jun;41(3):80-2. PMID: 3612413.
Copy Download .nbib Format: NLM
Strengthened ties between industry and academia are historical, productive, and crucial.

Survey of ophthalmology

Haller JA.
PMID: 24656436
Surv Ophthalmol. 2014 May-Jun;59(3):348-53. doi: 10.1016/j.survophthal.2013.07.004. Epub 2014 Mar 18.

Scientific collaboration between academia and industry has a long history in the United States and abroad. Initially U.S. companies took responsibility for patenting and licensing discoveries made in collaborating universities. A publicly funded "middle man", The Research Corporation, was...

Cite
Haller JA. Strengthened ties between industry and academia are historical, productive, and crucial. Surv Ophthalmol. 2014;59(3):348-53doi: 10.1016/j.survophthal.2013.07.004.
Haller, J. A. (2014). Strengthened ties between industry and academia are historical, productive, and crucial. Survey of ophthalmology, 59(3), 348-53. https://doi.org/10.1016/j.survophthal.2013.07.004
Haller, Julia A. "Strengthened ties between industry and academia are historical, productive, and crucial." Survey of ophthalmology vol. 59,3 (2014): 348-53. doi: https://doi.org/10.1016/j.survophthal.2013.07.004
Haller JA. Strengthened ties between industry and academia are historical, productive, and crucial. Surv Ophthalmol. 2014 May-Jun;59(3):348-53. doi: 10.1016/j.survophthal.2013.07.004. Epub 2014 Mar 18. PMID: 24656436.
Copy Download .nbib Format: NLM
Can we use social media to support content validity of patient-reported outcome instruments in medical product development?.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Rothman M, Gnanaskathy A, Wicks P, Papadopoulos EJ.
PMID: 25595228
Value Health. 2015 Jan;18(1):1-4. doi: 10.1016/j.jval.2014.10.001.

We report a panel designed to open a dialog between pharmaceutical sponsors, regulatory reviewers, and other stakeholders regarding the use of social media to collect data to support the content validity of patient-reported outcome instruments in the context of...

Cite
Rothman M, Gnanaskathy A, Wicks P, et al. Can we use social media to support content validity of patient-reported outcome instruments in medical product development?. Value Health. 2015;18(1):1-4doi: 10.1016/j.jval.2014.10.001.
Rothman, M., Gnanaskathy, A., Wicks, P., & Papadopoulos, E. J. (2015). Can we use social media to support content validity of patient-reported outcome instruments in medical product development?. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 18(1), 1-4. https://doi.org/10.1016/j.jval.2014.10.001
Rothman, Margaret, et al. "Can we use social media to support content validity of patient-reported outcome instruments in medical product development?." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 18,1 (2015): 1-4. doi: https://doi.org/10.1016/j.jval.2014.10.001
Rothman M, Gnanaskathy A, Wicks P, Papadopoulos EJ. Can we use social media to support content validity of patient-reported outcome instruments in medical product development?. Value Health. 2015 Jan;18(1):1-4. doi: 10.1016/j.jval.2014.10.001. PMID: 25595228.
Copy Download .nbib Format: NLM
Industry's role in continuing competency.

American pharmacy

Blake EM.
PMID: 7424794
Am Pharm. 1980 Sep;(9):52-3. doi: 10.1016/s0160-3450(16)31092-3.

No abstract available.

Cite
Blake EM. Industry's role in continuing competency. Am Pharm. 1980;(9):52-3doi: 10.1016/s0160-3450(16)31092-3.
Blake, E. M. (1980). Industry's role in continuing competency. American pharmacy, (9), 52-3. https://doi.org/10.1016/s0160-3450(16)31092-3
Blake, E M. "Industry's role in continuing competency." American pharmacy vol. ,9 (1980): 52-3. doi: https://doi.org/10.1016/s0160-3450(16)31092-3
Blake EM. Industry's role in continuing competency. Am Pharm. 1980 Sep;(9):52-3. doi: 10.1016/s0160-3450(16)31092-3. PMID: 7424794.
Copy Download .nbib Format: NLM
PDA comments on draft guidance for industry on changes to an approved NDA or ANDA. Parenteral Drug Association.

PDA journal of pharmaceutical science and technology

[No authors listed]
PMID: 10754723
PDA J Pharm Sci Technol. 1999 Sep-Oct;53(5):264-72.

No abstract available.

Cite
PDA comments on draft guidance for industry on changes to an approved NDA or ANDA. Parenteral Drug Association. PDA J Pharm Sci Technol. 1999;53(5):264-72
(1999). PDA comments on draft guidance for industry on changes to an approved NDA or ANDA. Parenteral Drug Association. PDA journal of pharmaceutical science and technology, 53(5), 264-72.
"PDA comments on draft guidance for industry on changes to an approved NDA or ANDA. Parenteral Drug Association." PDA journal of pharmaceutical science and technology vol. 53,5 (1999): 264-72.
PDA comments on draft guidance for industry on changes to an approved NDA or ANDA. Parenteral Drug Association. PDA J Pharm Sci Technol. 1999 Sep-Oct;53(5):264-72. PMID: 10754723.
Copy Download .nbib Format: NLM
Conflict of interest and the British Journal of Psychiatry.

The British journal of psychiatry : the journal of mental science

Wright IC.
PMID: 11772857
Br J Psychiatry. 2002 Jan;180:82-3. doi: 10.1192/bjp.180.1.82.

No abstract available.

Cite
Wright IC. Conflict of interest and the British Journal of Psychiatry. Br J Psychiatry. 2002;180:82-3doi: 10.1192/bjp.180.1.82.
Wright, I. C. (2002). Conflict of interest and the British Journal of Psychiatry. The British journal of psychiatry : the journal of mental science, 18082-3. https://doi.org/10.1192/bjp.180.1.82
Wright, I C. "Conflict of interest and the British Journal of Psychiatry." The British journal of psychiatry : the journal of mental science vol. 180 (2002): 82-3. doi: https://doi.org/10.1192/bjp.180.1.82
Wright IC. Conflict of interest and the British Journal of Psychiatry. Br J Psychiatry. 2002 Jan;180:82-3. doi: 10.1192/bjp.180.1.82. PMID: 11772857.
Copy Download .nbib Format: NLM
European researchers up in arms over new clinical trials edict.

Nature medicine

Bosch X.
PMID: 14595413
Nat Med. 2003 Nov;9(11):1336. doi: 10.1038/nm1103-1336b.

No abstract available.

Cite
Bosch X. European researchers up in arms over new clinical trials edict. Nat Med. 2003;9(11):1336doi: 10.1038/nm1103-1336b.
Bosch, X. (2003). European researchers up in arms over new clinical trials edict. Nature medicine, 9(11), 1336. https://doi.org/10.1038/nm1103-1336b
Bosch, Xavier. "European researchers up in arms over new clinical trials edict." Nature medicine vol. 9,11 (2003): 1336. doi: https://doi.org/10.1038/nm1103-1336b
Bosch X. European researchers up in arms over new clinical trials edict. Nat Med. 2003 Nov;9(11):1336. doi: 10.1038/nm1103-1336b. PMID: 14595413.
Copy Download .nbib Format: NLM
One year after launch, drug safety board is dubbed a failure.

Nature medicine

Wadman M.
PMID: 16520751
Nat Med. 2006 Mar;12(3):258. doi: 10.1038/nm0306-258b.

No abstract available.

Cite
Wadman M. One year after launch, drug safety board is dubbed a failure. Nat Med. 2006;12(3):258doi: 10.1038/nm0306-258b.
Wadman, M. (2006). One year after launch, drug safety board is dubbed a failure. Nature medicine, 12(3), 258. https://doi.org/10.1038/nm0306-258b
Wadman, Meredith. "One year after launch, drug safety board is dubbed a failure." Nature medicine vol. 12,3 (2006): 258. doi: https://doi.org/10.1038/nm0306-258b
Wadman M. One year after launch, drug safety board is dubbed a failure. Nat Med. 2006 Mar;12(3):258. doi: 10.1038/nm0306-258b. PMID: 16520751.
Copy Download .nbib Format: NLM
Consumer organisations criticise influence of drug companies.

BMJ (Clinical research ed.)

Kmietowicz Z.
PMID: 15499094
BMJ. 2004 Oct 23;329(7472):937. doi: 10.1136/bmj.329.7472.937.

No abstract available.

Cite
Kmietowicz Z. Consumer organisations criticise influence of drug companies. BMJ. 2004;329(7472):937doi: 10.1136/bmj.329.7472.937.
Kmietowicz, Z. (2004). Consumer organisations criticise influence of drug companies. BMJ (Clinical research ed.), 329(7472), 937. https://doi.org/10.1136/bmj.329.7472.937
Kmietowicz, Zosia. "Consumer organisations criticise influence of drug companies." BMJ (Clinical research ed.) vol. 329,7472 (2004): 937. doi: https://doi.org/10.1136/bmj.329.7472.937
Kmietowicz Z. Consumer organisations criticise influence of drug companies. BMJ. 2004 Oct 23;329(7472):937. doi: 10.1136/bmj.329.7472.937. PMID: 15499094; PMCID: PMC524098.
Copy Download .nbib Format: NLM
European and French pharmaceutical market assessed by Prescrire in 2005: mainly bogus innovation.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

[No authors listed]
PMID: 16796418
Farm Hosp. 2006 Mar-Apr;30(2):68-70.

No abstract available.

Cite
European and French pharmaceutical market assessed by Prescrire in 2005: mainly bogus innovation. Farm Hosp. 2006;30(2):68-70
(2006). European and French pharmaceutical market assessed by Prescrire in 2005: mainly bogus innovation. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 30(2), 68-70.
"European and French pharmaceutical market assessed by Prescrire in 2005: mainly bogus innovation." Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria vol. 30,2 (2006): 68-70.
European and French pharmaceutical market assessed by Prescrire in 2005: mainly bogus innovation. Farm Hosp. 2006 Mar-Apr;30(2):68-70. PMID: 16796418.
Copy Download .nbib Format: NLM
[Prescribe and advise freely].

Medecine tropicale : revue du Corps de sante colonial

[No authors listed]
PMID: 17286025
Med Trop (Mars). 2006 Dec;66(6):577-80.

Physicians know how totally unrealistic it is to expect drug companies to furnish reliable comparative information to assist therapeutic decision-making. All hope in this regard must be founded on personal effort to sort through available data and on independent...

Cite
Prescrire et conseiller en toute indépendance. [Prescribe and advise freely]. Med Trop (Mars). 2006;66(6):577-80
(2006). Prescrire et conseiller en toute indépendance. [Prescribe and advise freely]. Medecine tropicale : revue du Corps de sante colonial, 66(6), 577-80.
"Prescrire et conseiller en toute indépendance." [Prescribe and advise freely]. Medecine tropicale : revue du Corps de sante colonial vol. 66,6 (2006): 577-80.
Prescrire et conseiller en toute indépendance. [Prescribe and advise freely]. Med Trop (Mars). 2006 Dec;66(6):577-80. French. PMID: 17286025.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 66 entries